Gene · 92521
Papers3,158
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,681 to 1,700 of 3,158
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Structural biology in the time of COVID-19: perspectives on methods and milestones. | IUCrJ | 2021 | 33953920 | PubTator, text mining | PubMed |
| Innate immune sensing of coronavirus and viral evasion strategies. | Exp Mol Med | 2021 | 33953325 | PubTator, text mining | PubMed |
| Whole-genome classification of rotavirus C and genetic diversity of porcine strains in the USA. | J Gen Virol | 2021 | 33950806 | PubTator, text mining | PubMed |
| Should COVID-19 be branded to viral thrombotic fever? | Mem Inst Oswaldo Cruz | 2021 | 33950107 | PubTator, text mining | PubMed |
| The SARS-CoV-2 protein ORF3a inhibits fusion of autophagosomes with lysosomes. | Cell Discov | 2021 | 33947832 | PubTator, text mining | PubMed |
| ATPase and helicase activities of porcine epidemic diarrhea virus nsp13. | Vet Microbiol | 2021 | 33940460 | PubTator, text mining | PubMed |
| Elucidation of Cryptic and Allosteric Pockets within the SARS-CoV-2 Main Protease. | J Chem Inf Model | 2021 | 33939913 | PubTator, text mining | PubMed |
| Current updates on adaptive immune response by B cell and T cell stimulation and therapeutic strategies for novel coronavirus disease 2019 (COVID-19) treatment. | Heliyon | 2021 | 33937545 | PubTator, text mining | PubMed |
| SARS-CoV-2 worldwide replication drives rapid rise and selection of mutations across the viral genome: a time-course study - potential challenge for vaccines and therapies. | EMBO Mol Med | 2021 | 33931941 | PubTator, text mining | PubMed |
| A multiplex antigen microarray for simultaneous IgG and IgM detection against SARS-CoV-2 reveals higher seroprevalence than reported. | Microb Biotechnol | 2021 | 33929101 | PubTator, text mining | PubMed |
| SARS-CoV-2 mutations: the biological trackway towards viral fitness. | Epidemiol Infect | 2021 | 33928885 | PubTator, text mining | PubMed |
| The Rotavirus Vaccine Landscape, an Update. | Pathogens | 2021 | 33925924 | PubTator, text mining | PubMed |
| Mutation Signatures and In Silico Docking of Novel SARS-CoV-2 Variants of Concern. | Microorganisms | 2021 | 33925854 | PubTator, text mining | PubMed |
| NUP-98 Rearrangements Led to the Identification of Candidate Biomarkers for Primary Induction Failure in Pediatric Acute Myeloid Leukemia. | Int J Mol Sci | 2021 | 33925480 | PubTator, text mining | PubMed |
| COVID-19 Diagnostic Strategies Part II: Protein-Based Technologies. | Bioengineering (Basel) | 2021 | 33925032 | PubTator, text mining | PubMed |
| Identification of Anti-SARS-CoV-2 Compounds from Food Using QSAR-Based Virtual Screening, Molecular Docking, and Molecular Dynamics Simulation Analysis. | Pharmaceuticals (Basel) | 2021 | 33924395 | PubTator, text mining | PubMed |
| Incidence of Carassius auratus Gibelio Gill Hemorrhagic Disease Caused by CyHV-2 Infection Can Be Reduced by Vaccination with Polyhedra Incorporating Antigens. | Vaccines (Basel) | 2021 | 33923836 | PubTator, text mining | PubMed |
| From Multiplex Serology to Serolomics-A Novel Approach to the Antibody Response against the SARS-CoV-2 Proteome. | Viruses | 2021 | 33923338 | PubTator, text mining | PubMed |
| Baicalein and Baicalin Inhibit SARS-CoV-2 RNA-Dependent-RNA Polymerase. | Microorganisms | 2021 | 33921971 | PubTator, text mining | PubMed |
| Genetic Diversity of SARS-CoV-2 over a One-Year Period of the COVID-19 Pandemic: A Global Perspective. | Biomedicines | 2021 | 33920487 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/92521/papers?page=85